Literature DB >> 2340369

Prediction of response to radiotherapy in invasive bladder cancer.

B J Jenkins1, J E Martin, S I Baithun, R J Zuk, R T Oliver, J P Blandy.   

Abstract

The original pre-treatment histological sections from 125 patients with invasive (T2/T3) transitional cell bladder cancer treated by radical radiotherapy were studied; 63 tumours responded completely to radiation and 62 did not; 55 of 72 tumours containing areas of squamous metaplasia and 27 of 36 staining for beta-human chorionic gonadotrophin failed to respond to radiotherapy; 26 of 28 tumours showing both squamous metaplasia and beta-human chorionic gonadotrophin did not respond to radiation, whereas 40 of 45 tumours without either of these features responded. The DNA ploidy of 86 tumours in the series was measured by flow cytometry; 11 of 27 aneuploid and 30 of 59 diploid tumours responded to irradiation. Squamous metaplasia and beta-human chorionic gonadotrophin in bladder cancer indicate resistance to radiotherapy but DNA ploidy does not.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2340369     DOI: 10.1111/j.1464-410x.1990.tb14753.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  9 in total

1.  Urothelial carcinoma of the renal pelvis with simultaneous trophoblastic and malignant clear cell endodermal-type differentiation.

Authors:  Ovidiu Preda; Alis Dema; Mihaela Iacob; Pablo Goyenaga; Isabel Dulcey; José Aneiros Fernández; Francisco F Nogales
Journal:  Virchows Arch       Date:  2012-02-24       Impact factor: 4.064

2.  beta hCG as a prognostic marker in adenocarcinoma of the prostate.

Authors:  M T Sheaff; J E Martin; D F Badenoch; S I Baithun
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

Review 3.  New approaches in the use of radiation therapy in the treatment of infiltrative transitional-cell cancer of the bladder.

Authors:  P Warde; M K Gospodarowicz
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

4.  Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas.

Authors:  P Harnden; J Southgate
Journal:  J Clin Pathol       Date:  1997-12       Impact factor: 3.411

5.  A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma.

Authors:  Yoshiyuki Nagumo; Takahiro Kojima; Masanobu Shiga; Shuya Kandori; Tomokazu Kimura; Ei-Ichiro Takaoka; Mizuki Onozawa; Jun Miyazaki; Koji Kawai; Hitoshi Ishikawa; Hideyuki Sakurai; Hiroyuki Nishiyama
Journal:  Int J Clin Oncol       Date:  2019-10-08       Impact factor: 3.402

6.  Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis.

Authors:  S Youshya; K Purdie; J Breuer; C Proby; M T Sheaf; R T D Oliver; S Baithun
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

7.  Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract.

Authors:  C Langner; G Hutterer; T Chromecki; P Rehak; R Zigeuner
Journal:  Virchows Arch       Date:  2006-03-09       Impact factor: 4.064

8.  A correlation between nuclear supercoiling and the response of patients with bladder cancer to radiotherapy.

Authors:  T H Lynch; P Anderson; D M Wallace; G M Kondratowicz; R P Beaney; A T Vaughan
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

9.  Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer.

Authors:  S D Fosså; A A Berner; A B Jacobsen; H Waehre; B Kvarstein; T Urnes; P Ogreid; T E Johansen; J Silde; J M Nesland
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.